Cogent Biosciences, Inc. company logo
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) Cash From Financing

Annual CFF

$214.45M$50.92M+31.13%

Summary

Current Value
As of today, COGT annual cash from financing is $214.45M, up +31.13% on
Historical Performance
COGT annual cash from financing is up +464.70% over the past 3 years, and up +198465.74% over the past 5 years
All-Time High Comparison
COGT annual cash from financing is currently -7.64% below its historical high of $232.20M set on
3-Year Low Comparison
COGT annual cash from financing is +31.13% above its 3-year low of $163.54M reached on
Sector Comparison
COGT annual cash from financing is higher than 90.92% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

COGT Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$214.45M+31.1%+464.7%+10000.0%+203.1%
Quarterly Cash From Financing$217.37M+10000.0%+10000.0%+97.7%+100.0%
TTM Cash From Financing$289.59M+35.0%+43.9%+163.1%+100.0%
Price$35.57+338.6%+184.6%+198.7%
Annual Cash From Operations-$207.79M-35.3%-253.6%-400.5%-1272.9%
Annual Cash From Investing$38.28M+139.1%+2326.6%+65.3%+1278.1%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$17.47M-7.3%+453.6%+189.6%+100.0%
Shares Outstanding153.51M+39.0%+119.6%+374.6%

Cash From Financing Highs

COGT Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$214.45Mat high
5Y$232.20MN/A-7.6%
All$232.20M-7.6%

Cash From Financing Lows

COGT Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$163.54M+31.1%
5Y$37.98M+464.7%
All-$729.00K>+9999.0%

Cash From Financing History

YearValueChange
$214.45M+31.1%
$163.54M-0.0%
$163.56M+330.7%
$37.98M-83.6%
$232.20M>+9,900.0%
YearValueChange
$108.00K-99.8%
$70.35M+9,749.7%
-$729.00K-1,722.5%
-$40.00K-100.1%
$70.75M-

FAQ

  • What is the current annual cash from financing of COGT?

    As of today, COGT annual cash from financing is $214.45M

  • What is 1-year change in COGT annual cash from financing?

    COGT annual cash from financing is up +31.13% year-over-year

  • What is 3-year change in COGT annual cash from financing?

    COGT annual cash from financing is up +464.70% over the past 3 years

  • How far is COGT annual cash from financing from its all-time high?

    COGT annual cash from financing is currently -7.64% below its historical high of $232.20M set on December 31, 2020

  • How does COGT annual cash from financing rank versus sector peers?

    COGT annual cash from financing is higher than 90.92% of companies in Healthcare sector

  • When is COGT next annual earnings release?

    The next annual earnings release for COGT is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. COGT Official Website www.cogentbio.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1622229/000119312525272334/0001193125-25-272334-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1622229/000095017025026115/0000950170-25-026115-index.htm
  4. COGT Profile on Yahoo Finance finance.yahoo.com/quote/COGT
  5. COGT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cogt